{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:50:16Z","timestamp":1787169016779,"version":"build-2736575974"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejmech.2024.117060","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:12:14Z","timestamp":1731672734000},"page":"117060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["\u03b1-GalCer sp2-iminoglycolipid analogs as CD1d-dependent iNKT modulators: Evaluation of their immunotherapeutic potential in murine models of asthma and autoimmune hepatitis"],"prefix":"10.1016","volume":"282","author":[{"given":"Alan Chuan-Ying","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gonz\u00e1lez-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Hsin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yu","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Chien","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Mu\u00f1oz-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Garc\u00eda Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7676-7721","authenticated-orcid":false,"given":"Carmen","family":"Ortiz Mellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.117060_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"Bendelac","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3369","article-title":"Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions","volume":"13","author":"Brennan","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.molimm.2020.12.005","article-title":"Reading the room: iNKT cells influence B cell responses","volume":"130","author":"Leadbetter","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-006-6073-z","article-title":"Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands","volume":"63","author":"Tsuji","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2024.117060_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri3328","article-title":"Recognition of CD1d-restricted antigens by natural killer T cells","volume":"12","author":"Rossjohn","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-immunol-032414-112008","article-title":"The immunology of CD1- and MR1-restricted T Cells","volume":"34","author":"Mori","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib7","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fimmu.2017.01178","article-title":"Natural killer T cells in cancer immunotherapy","volume":"8","author":"Nair","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0952-7915(02)00316-3","article-title":"NKT cells - conductors of tumor immunity?","volume":"14","author":"Smyth","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2022.108527","article-title":"iNKT cell agonists as vaccine adjuvants to combat infectious diseases","volume":"513","author":"Li","year":"2022","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2024.117060_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00232-20","article-title":"Type I natural killer T cells as key regulators of the immune response to infectious diseases","volume":"34","author":"G\u00e1lvez","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2024.117060_bib11","first-page":"510","article-title":"Therapeutic potential of invariant natural Killer T Cells in autoimmunity","volume":"9","author":"Kaer","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cyto.2010.11.001","article-title":"Mechanism of regulation of autoimmunity by iNKT cells","volume":"53","author":"Novak","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.ejmech.2024.117060_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00441-010-1023-3","article-title":"Invariant natural killer T cells: bridging innate and adaptive immunity","volume":"343","author":"Kaer","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejmech.2024.117060_bib14","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1016\/S0040-4020(01)86991-X","article-title":"Agelasphins, novel antitumor and immunostimulatory cerebrosides from the marine sponge Agelas mauritianus","volume":"50","author":"Natori","year":"1994","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.117060_bib15","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm00012a018","article-title":"Structure-activity relationship of \u03b1-galactosylceramides against B16-bearing mice","volume":"38","author":"Morita","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ni1225","article-title":"The crystal structure of human CD1d with and without \u03b1-galactosylceramide","volume":"6","author":"Koch","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ni1224","article-title":"Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor","volume":"6","author":"Zajonc","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nature05907","article-title":"CD1d\u2013lipid-antigen recognition by the semi-invariant NKT T-cell receptor","volume":"448","author":"Borg","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.117060_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2217\/imt.13.175","article-title":"Optimizing NKT cell ligands as vaccine adjuvants","volume":"6","author":"Carreno","year":"2014","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ejmech.2024.117060_bib20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molimm.2020.12.015","article-title":"Exploiting CD1-restricted T cells for clinical benefit","volume":"132","author":"Exley","year":"2021","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib21","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1073\/pnas.0703824104","article-title":"Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids","volume":"104","author":"Chang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.117060_bib22","doi-asserted-by":"crossref","first-page":"12348","DOI":"10.1021\/ja8012787","article-title":"Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production","volume":"130","author":"Liang","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117060_bib23","doi-asserted-by":"crossref","first-page":"15662","DOI":"10.3390\/molecules181215662","article-title":"Stimulation of natural killer T cells by glycolipids","volume":"18","author":"Anderson","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.117060_bib24","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1021\/jm4010863","article-title":"Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory Effect: molecular Bases","volume":"57","author":"Laurent","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib25","doi-asserted-by":"crossref","first-page":"13602","DOI":"10.1021\/ja045385q","article-title":"Effects of lipid chain lengths in \u03b1-galactosylceramides on cytokine release by natural killer T cells","volume":"126","author":"Goff","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117060_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35097097","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.117060_bib27","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1002\/anie.201802983","article-title":"Potent Th2 cytokine bias of natural killer T cell by CD1d glycolipids: anchoring effect of polar groups in the lipid component","volume":"57","author":"Inuki","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117060_bib28","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.bmcl.2019.02.018","article-title":"Structure-activity relationship studies of Bz-amide containing \u03b1-GalCer derivatives as natural killer T cell modulators","volume":"29","author":"Kishi","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1021\/jm061243q","article-title":"Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant \u03b1-GalCer","volume":"50","author":"Lee","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib30","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1021\/ja062740z","article-title":"Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity","volume":"128","author":"Fujio","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117060_bib31","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.1006662107","article-title":"Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant","volume":"107","author":"Li","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.117060_bib32","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1128\/AAC.00368-10","article-title":"In vivo protection provided by a synthetic new alpha-galactosyl ceramide analog against bacterial and viral infections in murine models","volume":"54","author":"Lin","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.117060_bib33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri3328","article-title":"Recognition of CD1d-restricted antigens by natural killer T cells","volume":"12","author":"Rossjohn","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib34","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/cmdc.200900350","article-title":"The roles of 3\u2019 and 4\u2019 hydroxy groups in \u03b1-galactosylceramide stimulation of invariant natural killer T cells","volume":"4","author":"Xia","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.117060_bib35","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1021\/acschembio.0c00707","article-title":"Amide-linked C4\u2033-saccharide modification of KRN7000 provides potent stimulation of human invariant NKT cells and anti-tumor immunity in a humanized mouse model","volume":"15","author":"Saavedra-Avila","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117060_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cmdc.201800649","article-title":"4\u201d-O-Alkylated \u03b1-galactosylceramide analogues as iNKT-cell antigens: synthetic, biological, and structural studies","volume":"14","author":"Janssens","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.117060_bib37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/acsmedchemlett.7b00107","article-title":"Efficient divergent synthesis of new immunostimulant 4\u201d-modified \u03b1-galactosylceramide analogues","volume":"8","author":"Janssens","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib38","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1021\/acsinfecdis.2c00296","article-title":"A new iNKT-cell agonist-adjuvanted SARS-CoV-2 subunit vaccine elicits robust neutralizing antibody responses","volume":"8","author":"Li","year":"2022","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.117060_bib39","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1021\/acs.jmedchem.1c02000","article-title":"Self-adjuvanting lipoprotein conjugate \u03b1-GalCer-RBD induces potent immunity against SARS-CoV-2 and its variants of concern","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib40","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/acs.jmedchem.0c01186","article-title":"Synthesis and evaluation of liposomal anti-GM3 cancer vaccine candidates covalently and noncovalently adjuvanted by \u03b1-GalCer","volume":"64","author":"Yin","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib41","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1021\/acs.jmedchem.8b00312","article-title":"Synthesis, liposomal formulation, and immunological evaluation of a minimalistic carbohydrate-\u03b1-GalCer vaccine candidate","volume":"61","author":"Broecker","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib42","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1038\/emboj.2011.145","article-title":"Galactose\u2010modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis","volume":"30","author":"Aspeslagh","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2024.117060_bib43","doi-asserted-by":"crossref","first-page":"16468","DOI":"10.1021\/ja8064182","article-title":"6\u2032-Derivatised \u03b1-GalCer analogues capable of inducing strong CD1d-mediated Th1-biased NKT cell responses in mice","volume":"130","author":"Trappeniers","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117060_bib44","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1021\/acsmedchemlett.3c00154","article-title":"Conformationally restricted analogues of \u03b1-galactosylceramide as adjuvant in COVID-19 subunit vaccine","volume":"14","author":"Hu","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib45","article-title":"Diversity-oriented synthesis of a molecular library of \u03b1-galactosylceramides with fluorous-tag-assisted purification and evaluation of their bioactivities in regard to IL-2 secretion","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.117060_bib46","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1021\/acschembio.6b00650","article-title":"Phenyl glycolipids with different glycosyl groups exhibit marked differences in murine and human iNKT cell activation","volume":"11","author":"Wu","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2024.117060_bib47","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1073\/pnas.0604812103","article-title":"Glycolipid \u03b1-C-galactosylceramide is a distinct inducer of dentritic cell function during innate and adaptive immune responses of mice","volume":"103","author":"Fujii","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.117060_bib48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.clim.2011.03.016","article-title":"Activation of human invariant natural killer T cells with a thioglycoside analogue of \u03b1-galactosylceramide","volume":"140","author":"Hogan","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib49","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/biom10040532","article-title":"Structural dynamics of the lipid antigen-binding site of CD1d protein","volume":"1","author":"Cuevas-Zuvir\u00eda","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2024.117060_bib50","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41590-019-0504-0","article-title":"Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin","volume":"20","author":"Melum","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.897873","article-title":"Sortase A-cleavable CD1d identifies sphingomyelins as major class of CD1d-associated lipids","volume":"13","author":"Rudolph","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib52","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1016\/j.cell.2023.08.022","article-title":"CD1 lipidomes reveal lipid-binding motifs and size-based antigen-display mechanisms","volume":"186","author":"Huang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.117060_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102339","article-title":"CD1 displays its own negative regulators","volume":"83","author":"Shahine","year":"2023","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ymgme.2013.01.018","article-title":"Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease","volume":"108","author":"Pereira","year":"2013","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ejmech.2024.117060_bib55","doi-asserted-by":"crossref","first-page":"12254","DOI":"10.1073\/pnas.0404632101","article-title":"The T cell antigen receptor expressed by V\u03b114i NKT cells has a unique mode of glycosphingolipid antigen recognition","volume":"101","author":"Sidobre","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.117060_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/intimm\/dxr108","article-title":"Sulfatide inhibits \u03b1-galactosylceramide presentation by dendritic cells","volume":"24","author":"Kanamori","year":"2012","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.0906-6705.2005.00289.x","article-title":"CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity","volume":"14","author":"Nieuwenhuis","year":"2005","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ejmech.2024.117060_bib58","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3389\/fimmu.2019.01065","article-title":"Inflammatory phenotype of intrahepatic sulfatide-reactive type II NKT cells in humans with autoimmune hepatitis","volume":"10","author":"Sebode","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fchem.2019.00811","article-title":"\u03b1-Lactosylceramide protects against iNKT-mediated murine airway hyperreactivity and liver injury through competitive inhibition of CD1d binding","volume":"7","author":"Lai","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121620","article-title":"Natural killer T cells and the invariant subset promote atherosclerosis: a meta-analysis","volume":"321","author":"Chakrabarti","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2024.117060_bib61","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/cvr\/cvv259","article-title":"A CD1d-dependent lipid antagonist to NKT cells ameliorates atherosclerosis in ApoE\u2212\/\u2212 mice by reducing lesion necrosis and inflammation","volume":"109","author":"Li","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2024.117060_bib62","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/s12276-023-01053-6","article-title":"CD1-mediated immune responses in mucosal tissues: molecular mechanisms underlying lipid antigen presentation system","volume":"55","author":"Kim","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2024.117060_bib63","doi-asserted-by":"crossref","first-page":"5174","DOI":"10.3390\/cancers13205174","article-title":"The current landscape of NKT cell immunotherapy and the hills ahead","volume":"13","author":"Nelson","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2024.117060_bib64","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5114\/ceji.2017.69361","article-title":"A brief review of clinical trials involving manipulation of Invariant NKT cells as a promising approach in future cancer therapies","volume":"2","author":"Waldowska","year":"2017","journal-title":"Cent. Eur. J. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562864231162153","article-title":"First-in-human clinical trial of the NKT cell-stimulatory glycolipid OCH in multiple sclerosis","volume":"16","author":"Sato","year":"2023","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"4","key":"10.1016\/j.ejmech.2024.117060_bib66","first-page":"799","article-title":"Synthesis and biological evaluation of peptide-adjuvant conjugate vaccines with increasing antigen content","volume":"34","author":"Cooney","year":"2023","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib67","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1038\/s41467-023-39738-1","article-title":"An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo","volume":"14","author":"Tsuji","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.117060_bib68","article-title":"Diversification of a novel \u03b1-galactosyl ceramide hotspot boosts the adjuvant properties in parenteral and mucosal vaccines","author":"M\u00e9ndez","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.117060_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1401","article-title":"Glycolipid-peptide conjugate vaccines elicit CD8+ T-cell responses and prevent breast cancer metastasis","author":"Burn","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib70","article-title":"Chemical biology of \u03b1-GalCer: a chemist's toolbox for the stimulation of invariant natural killer T (iNKT) Cells","author":"Romano","year":"2022","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib71","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1039\/a705755e","article-title":"N-Thiocarbonyl azasugars: a new family of carbohydrate mimics with controlled anomeric configuration","author":"Jim\u00e9nez Blanco","year":"1997","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117060_bib72","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1039\/b906968b","article-title":"Glycosidase inhibition by ring-modified castanospermine analogues: tackling enzyme selectivity by inhibitor tailoring","volume":"7","author":"Aguilar-Moncayo","year":"2009","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib73","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1002\/cbic.201000323","article-title":"A Fluorescent sp2-iminosugar with pharmacological chaperone activity for Gaucher disease: synthesis and intracellular distribution studies","volume":"11","author":"Luan","year":"2010","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2024.117060_bib74","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejmech.2015.08.038","article-title":"Inhibitor versus chaperone behavior of D-fagomine, DAB and LAB sp2-iminosugar conjugates against glycosidases: a structure-activity relationship study in Gaucher fibroblasts","volume":"121","author":"Mena-Barragan","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib75","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1039\/c0cc00446d","article-title":"Synthesis of N-, S-, and C-glycoside castanospermine analogues with selective neutral \u03b1-glucosidase inhibitory activity as antitumour agents","volume":"46","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117060_bib76","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1021\/ol901125n","article-title":"Generalized anomeric effect in gem-diamines: stereoselective synthesis of \u03b1-N-linked disaccharide mimics","volume":"11","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib77","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1002\/chem.201200279","article-title":"sp2-Iminosugar O-, S-, and N-glycosides as conformational mimics of \u03b1-linked disaccharides; implications for glycosidase inhibition","volume":"18","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2012","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2024.117060_bib78","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1021\/acs.jmedchem.2c01948","article-title":"Serine-\/cysteine-based sp2-iminoglycolipids as novel TLR4 agonists: evaluation of their adjuvancy and immunotherapeutic properties in a murine model of asthma","volume":"66","author":"Gonzalez-Cuesta","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib79","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1021\/jacs.1c10504","article-title":"Bicyclic picomolar OGA inhibitors enable chemoproteomic mapping of its endogenous post-translational modifications","volume":"144","author":"Gonz\u00e1lez-Cuesta","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.117060_bib80","doi-asserted-by":"crossref","first-page":"22394","DOI":"10.1021\/acsomega.2c01469","article-title":"Stereoselective synthesis of nojirimycin \u03b1-C-glycosides from a bicyclic acyliminium intermediate: a convenient entry to N,C-biantennary glycomimetics","volume":"7","author":"Herrera-Gonz\u00e1lez","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.117060_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107555","article-title":"sp2-Iminosugar azobenzene O-glycosides: light-sensitive glycosidase inhibitors with unprecedented tunability and switching factors","author":"Rivero-Barbarroja","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib82","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1080\/14756366.2022.2073444","article-title":"sp2-Iminosugars targeting human lysosomal \u03b2-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease","volume":"37","author":"Gonz\u00e1lez-Cuesta","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib83","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1021\/acs.jmedchem.9b00153","article-title":"Pharmacological chaperones for the treatment of \u03b1-mannosidosis","volume":"62","author":"R\u00edsquez-Cuadro","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib84","doi-asserted-by":"crossref","first-page":"12086","DOI":"10.1039\/D2CC04478A","article-title":"Mannobioside biomimetics that trigger DC-SIGN binding selectivity","volume":"58","author":"Herrera-Gonz\u00e1lez","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.117060_bib85","article-title":"High-mannose oligosaccharide hemimimetics that recapitulate the conformation and binding mode to concanavalin A, DC-SIGN and langerin","author":"Herrera-Gonz\u00e1lez","year":"2023","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2024.117060_bib86","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1039\/D3NH00363A","article-title":"A selenoureido-iminoglycolipid transported by zeolitic-imidazolate framework nanoparticles: a novel antioxidant therapeutic approach","volume":"8","author":"Guerrero","year":"2023","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.ejmech.2024.117060_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115390","article-title":"Fluoro-labelled sp2-iminoglycolipids with immunomodulatory properties","volume":"255","author":"Padilla-P\u00e9rez","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib88","doi-asserted-by":"crossref","first-page":"8450","DOI":"10.3390\/ijms23158450","article-title":"Unravelling the inflammatory processes in the early stages of diabetic nephropathy and the potential effect of (SS)-DS-ONJ","volume":"23","author":"G\u00f3mez-Jaramillo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.117060_bib89","doi-asserted-by":"crossref","first-page":"8524","DOI":"10.1021\/acs.jmedchem.0c00908","article-title":"Amplified detection of breast cancer autoantibodies using MUC1-based Tn antigen mimics","volume":"63","author":"Guillen-Poza","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib90","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1039\/C9SC06334J","article-title":"Synthesis, conformational analysis and in vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp2-iminosugar fragment","volume":"11","author":"Bermejo","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2024.117060_bib91","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/acsmedchemlett.5b00046","article-title":"Synthesis and biological activities of 5-thio-\u03b1-GalCers","volume":"6","author":"Bi","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib92","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1021\/jo991242o","article-title":"Generalized anomeric effect in action: synthesis and evaluation of stable reducing indolizidine glycomimetics as glycosidase inhibitors","volume":"65","author":"D\u00edaz P\u00e9rez","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib93","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1021\/acs.orglett.6b01899","article-title":"Tn antigen mimics based on sp2-iminosugars with affinity for an anti-MUC1 antibody","volume":"18","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2016","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib94","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1021\/ol050659f","article-title":"Efficient synthesis of \u03b1-galactosyl ceramide analogues using glycosyl iodide donors","volume":"7","author":"Du","year":"2005","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2009.05.095","article-title":"Synthesis and biological activity of \u03b1-galactosyl ceramide KRN7000 and galactosyl (\u03b11\u21922) galactosyl ceramide","volume":"19","author":"Veerapen","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib96","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.4049\/jimmunol.1500203","article-title":"Selective conditions are required for the induction of invariant NKT cell hyporesponsiveness by antigenic stimulation","volume":"195","author":"Wingender","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib97","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.4049\/jimmunol.174.6.3179","article-title":"The mouse CD1d cytoplasmic tail mediates CD1d trafficking and antigen presentation by adaptor protein 3-dependent and -independent mechanisms","volume":"174","author":"Lawton","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib98","doi-asserted-by":"crossref","first-page":"924","DOI":"10.4049\/jimmunol.1500070","article-title":"A novel glycolipid antigen for NKT cells that preferentially induces IFN-\u03b3 Production","volume":"195","author":"Birkholz","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib99","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3390\/cells12242854","article-title":"Natural killer T (NKT) cells in autoimmune hepatitis: current evidence from basic and clinical research","volume":"12","author":"Poddighe","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2024.117060_bib100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/biol-2022-0013","article-title":"Concanavalin A-induced autoimmune hepatitis model in mice: mechanisms and future outlook","volume":"28","author":"Liu","year":"2022","journal-title":"Open Life Sci."},{"key":"10.1016\/j.ejmech.2024.117060_bib101","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1586\/17474124.2015.1056738","article-title":"Natural killer T cells in liver injury, inflammation and cancer","volume":"9","author":"Wang","year":"2015","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.117060_bib102","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.21174","article-title":"Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism","volume":"43","author":"Li","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2024.117060_bib103","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4049\/jimmunol.171.4.1637","article-title":"Cutting edge: invariant V\u03b114 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model","volume":"171","author":"Lisbonne","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib104","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s12276-023-01024-x","article-title":"Invariant natural killer T cells in lung diseases","volume":"55","author":"Jeong","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2024.117060_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1364774","article-title":"Natural killer T cells in allergic asthma: implications for the development of novel immunotherapeutical strategies","volume":"15","author":"Guti\u00e9rrez-Vera","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.117060_bib106","first-page":"10299","article-title":"Glycolipid activation of invariant T cell receptor+ NKT cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells","volume":"104","author":"Meyer","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.117060_bib107","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1002\/ejoc.200500071","article-title":"Synthesis and comparative glycosidase inhibitory properties of reducing castanospermine analogues","volume":"14","author":"D\u00edaz P\u00e9rez","year":"2005","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib108","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1021\/jo991242o","article-title":"Generalized anomeric effect in action: synthesis and evaluation of stable reducing indolizidine glycomimetics as glycosidase inhibitors","volume":"65","author":"D\u00edaz P\u00e9rez","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.117060_bib109","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1021\/acsmedchemlett.5b00046","article-title":"Synthesis and biological activities of 5-thio-\u03b1-GalCers","volume":"6","author":"Bi","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.117060_bib110","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1016\/j.bmcl.2009.05.095","article-title":"Synthesis and biological activity of \u03b1-galactosyl ceramide KRN7000 and galactosyl (\u03b11\u2192 2) galactosyl ceramide","volume":"19","author":"Veerapen","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117060_bib111","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.immuni.2009.04.018","article-title":"Differential recognition of CD1d-\u03b1-galactosyl ceramide by the V\u03b28.2 and V\u03b27 semi-invariant NKT T cell receptors","volume":"31","author":"Pellicci","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2024.117060_bib112","series-title":"The PyMOL Molecular Graphics System","author":"Schr\u00f6dinger","year":"2015"},{"issue":"1","key":"10.1016\/j.ejmech.2024.117060_bib113","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41597-019-0177-4","article-title":"BioExcel building blocks, a software library for interoperable biomolecular simulation workflows","volume":"6","author":"Andrio","year":"2019","journal-title":"Sci. Data"},{"issue":"8","key":"10.1016\/j.ejmech.2024.117060_bib114","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"Ff14SB: improving the accuracy of protein side chain and backbone parameters from Ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"issue":"9","key":"10.1016\/j.ejmech.2024.117060_bib115","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2024.117060_bib116","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"5","key":"10.1016\/j.ejmech.2024.117060_bib117","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1063\/1.1332996","article-title":"Langevin stabilization of molecular dynamics","volume":"114","author":"Izaguirre","year":"2001","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.117060_bib118","volume":"2020","author":"Case","year":"2020","journal-title":"AMBER"},{"key":"10.1016\/j.ejmech.2024.117060_bib119","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.1063\/1.465608","article-title":"The effect of long\u2010range electrostatic interactions in simulations of macromolecular crystals: a comparison of the Ewald and truncated list methods","volume":"99","author":"York","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.117060_bib120","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1063\/1.470043","article-title":"Accuracy and efficiency of the Particle mesh Ewald method","volume":"103","author":"Petersen","year":"1995","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2024.117060_bib121","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.ejmech.2024.117060_bib122","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/jcc.540130805","article-title":"Settle: an analytical version of the SHAKE and RATTLE algorithm for rigid water models","volume":"13","author":"Miyamoto","year":"1992","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.117060_bib123","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","article-title":"ProLIF: a library to encode molecular interactions as Fingerprints","volume":"13","author":"Bouysset","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.ejmech.2024.117060_bib124","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424009425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:18:19Z","timestamp":1733498299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424009425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":124,"alternative-id":["S0223523424009425"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117060","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b1-GalCer sp2-iminoglycolipid analogs as CD1d-dependent iNKT modulators: Evaluation of their immunotherapeutic potential in murine models of asthma and autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.117060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117060"}}